Infosecurity outlines key recommendations for CISOs and security teams to implement safeguards for AI-assisted coding ...

Forbes contributors publish independent expert analyses and insights. John Sviokla covers GenAI/AI's impact on commerce and society. This voice experience is generated by AI. Learn more. This voice ...

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Recursion Pharmaceuticals (RXRX) shares have been drawing ...

Jennifer Nelson writes about all things money--personal finance, investing, saving, credit cards and insurance for numerous publications including AARP, Next Avenue, Credit Karma, Real SImple, Citi ...

As a staff writer for Forbes Advisor, SMB, Kristy helps small business owners find the tools they need to keep their businesses running. She uses the experience of managing her own writing and editing ...

This website uses tracking technologies to enable our website functionalities, to enhance user experience or to analyze performance and traffic. We may also share or sell information about your use of ...

Get news and updates about your favorite shows, plus so much more.

Investing.com - Recursion Pharmaceuticals (NASDAQ: RXRX) reported fourth quarter EPS of $-0.31, $0.02 worse than the analyst ...

Jessica Gibson is a content update editor and writer for Investopedia. She has over 10 years of experience in digital publishing and three years of experience covering financial topics like insurance, ...

Recursion (Nasdaq: RXRX) said on Wednesday that it had named Vicki Goodman as chief medical officer, effective April 6, 2026, succeeding David Mauro. Goodman had more than two decades of experience in ...